Russian Government Starts Using Scopus for National Research Assessment

   Russian Government Starts Using Scopus for National Research Assessment

  PR Newswire

  MOSCOW, January 22, 2013

MOSCOW, January 22, 2013 /PRNewswire/ --

  Scopus used as assessment tool within Russia's state program "Science and
                      Technology Development 2013-2020"

Elsevier , a world-leading provider of scientific, technical and medical
information products and services, today announced that the Russian government
has officially selected Scopus as a tool for its national research assessment.
Measuring research performance forms a significant part of Russia's "Science
and Technology Development in 2013-2020" program as declared by Prime Minister
Dmitry Medvedev in 2012.

The aim of Russia's "Science and Technology Development in 2013-2020" program
is to create an internationally competitive and well-functioning R&D sector,
one in which efforts to modernize the economy are supported by science,
technology and innovation. Within the program there is an emphasis on research
assessment, measuring not only quantity but also quality of research output.
Using data from Scopus, the Russian government will be able to map out its
national research landscape, and compare it with other countries.

Ivan Sterligov, Director of Center of Situational Analysis at Russia's
Ministry of Education and Science, noted, "Our state program is aimed at
creating an innovative, secure infrastructure for Russian science and increase
the efficiency of our fundamental and applied research. It will allow us to
allocate financial resources to priority areas in science and technology. As a
widely recognized and trusted source of scientific data, Scopus will help us
define effective criteria for this."

Igor Osipov, PhD, Elsevier Regional Director for Russia and Belarus said,
"Elsevier is honored to further develop its collaboration with the Russian
government. Scopus will provide baseline data to assess research output across
Russia in a strategic, forward-looking manner. We consider the launch of the
program by Prime Minister Dmitry Medvedev a landmark event in the reform of
science and education and a significant step towards quality benchmarking data
for Russian researchers and decision makers, both in Russia and in an
international context."

About Scopus

Covering the world's research literature, Scopus is the largest abstract and
citation database of peer-reviewed literature. Featuring smart tools to track,
analyze and visualize research, Scopus was designed and developed with input
from over 500 users and librarians internationally. Its unique database
contains abstracts and references from nearly 20,500 peer-reviewed journals
from more than 5,000 publishers worldwide, ensuring broad interdisciplinary
coverage. Direct links to subscribed full-text articles, library resources and
other applications like reference management software, make Scopus quicker,
easier and more comprehensive to use than any other literature research

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet and Cell , and close to 20,000 book titles, including
major reference works from Mosby and Saunders. Elsevier's online solutions
include ScienceDirect , Scopus , Reaxys , ClinicalKey and Mosby's Nursing
Suite , which enhance the productivity of science and health professionals,
and the SciVal suite and MEDai's Pinpoint Review , which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC , a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL
(London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact Galina Yakshonak Elsevier, Russia +7-985-72-779-67
Press spacebar to pause and continue. Press esc to stop.